Analysts discuss Transthyretin Amyloid Cardiomyopathy (ATTR-CM) (relevant companies ALNY, IONS, BBIO) on an Analyst/Industry conference call to be held on August 30 at 11:30 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY:
- Ionis Pharmaceuticals price target raised to $55 from $50 at JPMorgan
- Alnylam price target raised to $280 from $248 at JPMorgan
- Goldman upgrades Alnylam to Buy ahead of ‘fundamental re-rating’
- Alnylam upgraded to Buy from Neutral at Goldman Sachs
- Alnylam price target raised to $342 from $291 at Citi
Questions or Comments about the article? Write to editor@tipranks.com